Advertisement
News
Advertisement

Teleflex lands FDA win for Arrow UltraQuik needles

Fri, 01/25/2013 - 1:29pm
Mass Device

Medical device company Teleflex touts 510(k) clearance for its Arrow UltraQuik peripheral nerve block needles.

Teleflex logo

Limerick, Pa.-based Teleflex (NYSE:TFX) won FDA clearance for the latest in its line of peripheral nerve block needles, the Arrow UltraQuik.

The Arrow UltraQuik joins Teleflex's StimuQuik and StimuQuik Echo, devices aimed at helping physicians perform nerve blocking, whether with ultrasound alone, via nerve stimulation, or through a combined approach, according to a press release.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading